ArticleJournal of experimental & clinical cancer research : CR2023

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.

E C de Heer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.